1 results match your criteria: "University Hospital of Oslo and University of Oslo[Affiliation]"
Considerations for SGLT2 inhibitor use in post-transplantation diabetes.
Nat Rev Nephrol
September 2019
Department of Organ Transplantation, Section of Nephrology, University Hospital of Oslo and University of Oslo, Oslo, Norway.